Eurofins Scientific SE provided revenue guidance for the fiscal year 2024. For the year, the company expects revenue including M&A of 7,250 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.08 EUR | +3.23% | +4.27% | +1.87% |
May. 13 | Eurofins Scientific to Expand US Battery Materials Testing Capabilities | MT |
May. 13 | Eurofins Scientific expands capacity in the USA | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.87% | 12.59B | |
-28.75% | 70.63B | |
+2.04% | 27.05B | |
-6.19% | 17.97B | |
+2.32% | 17.58B | |
+2.10% | 15.64B | |
+7.06% | 13.55B | |
+10.80% | 13.41B | |
+71.31% | 13.18B | |
+75.96% | 12.99B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Provides Revenue Guidance for the Fiscal Year 2024